Skip to main content

News

PQT/AMD newsletter - Q3 2026, Issue 54 is now available

ID
IVD
MD
Announcement
30 September, 2026 - 17:11 (CEST)

We are pleased to share the latest edition of our newsletter, featuring recent updates, key developments, and other relevant information. 

We invite you to read the newsletter and sta

Active Pharmaceutical Ingredient (API) Prequalified

M
Announcement
17 September, 2026 - 12:12 (CEST)

Lamivudine manufactured by Jiangxi Desano Pharmaceutical Co. Ltd. has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

Active Pharmaceutical Ingredient (API) Prequalified

M
Announcement
16 September, 2026 - 12:12 (CEST)

Bedaquiline (fumarate) manufactured by Arene Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

New EUL listing

ID
IVD
Announcement
9 September, 2026 - 09:35 (CEST)

WHO has listed the QuantiVirus MPXV Test Kit, manufactured by DiaCarta Inc., under its Emergency Use Listing (EUL) procedure, expanding ac

New EUL listing

ID
IVD
Announcement
2 September, 2026 - 14:38 (CEST)

Effective outbreak control begins with accurate and timely diagnosis.

Active Pharmaceutical Ingredient (API) Prequalified

M
Announcement
24 August, 2026 - 00:12 (CEST)

Pyrazinamide manufactured by Resonance Specialities Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

2 additional tests listed under the EUL for IVDs

IVD
Announcement
7 August, 2026

The RealStar Filovirus Screen RT-PCR Kit 1.0, manufactured by Diagnostics GmbH, and the RADIONE Ebola/Marburg Detection Kit, manufactured by KH Medical Co., Ltd., have now received WHO Emergency Us

Active Pharmaceutical Ingredient (API) Prequalified

M
Announcement
31 July, 2026 - 12:12 (CEST)

Ritonavir manufactured by Qidong Dongyue Pharmaceutical Co., Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

WHO's Public Assessment Reports (WHOPAR) Update

ID
IVD
Alerts
24 July, 2026 - 17:26 (CEST)

Between 20 June and 21 July 2026, several WHO Public Assessment Reports (WHOPARs) were updated to reflect changes in product labelling, documentation, and other relevant post-prequ

WHO's Public Assessment Reports (WHOPAR) Update

IVD
Alerts
19 June, 2026 - 15:35 (CEST)

Between 27 May and 19 June 2026, several WHO Public Assessment Reports (WHOPARs) were updated to reflect changes in product labelling, documentation, and other relevant post-prequa

Update on EUL for Bundibugyo Virus IVDs

IVD
Alerts
19 June, 2026 - 12:28 (CEST)
WHO has published an update on the status of ongoing Emergency Use Listing (EUL) applications for in vitro diagnostics (IVDs) for Bundibugyo virus disease (BDBV).

Prequalification workshop for manufacturers of IVDs

IVD
Announcement
15 June, 2026 - 11:37 (CEST)

A WHO workshop brought together manufacturers of IVDs, to advance access to quality-assured diagnostics, with a focus on strengthening understanding of prequalification req